CBD Chewing Gum: A Plausible Idea With Very Little Clinical Proof
The CBD chewing gum clinical trial reveals no significant benefit over placebo, underscoring the need for more research. Despite its plausible drug delivery concept, clinical proof remains limited. Understanding the trial outcomes helps guide patient…
Tiny Pilot Study Hints at Possible Benefits of Probiotics Plus PEA for Osteoarthritis—But Far Too Early to Draw Conclusions
This pilot study investigates probiotics PEA osteoarthritis pain in four participants. Only one showed clear pain reduction, though functional and wellbeing improvements appeared more broadly. The findings are preliminary and highlight the need for…
Cannabidiol in Anorexia Nervosa: A Double-Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change.
This pilot study evaluates cbd anorexia nervosa safety in a randomized, placebo-controlled trial. It focuses on tolerability and pharmacokinetics in affected women. The findings provide preliminary safety data for future research.
Behavioural, Pharmacokinetic, and Genetic Evidence of CBD-Oxycodone Interaction in Mice
This study investigated cannabidiol oxycodone interaction and its effects on opioid analgesia and pharmacokinetics. Acute CBD administration increased oxycodone exposure and analgesic duration. Chronic use accelerated tolerance development specific to…
Medically Recommended Cannabis Use for US Adolescents.
This study examines medically recommended cannabis use adolescents using nationally representative data. It reveals 5.2% of adolescent cannabis users have medical recommendations. Understanding medically recommended cannabis use adolescents informs…
Unlocking the Multifaceted Role of CB
CB1 receptor pharmacology research reveals the complex signaling of the endocannabinoid system. This complexity explains the challenges in developing cannabinoid therapeutics. Understanding CB1 receptor roles is key to advancing clinical outcomes.
Cannabidiphorol (CBDP) as a Negative Allosteric Modulator at CB1
This article discusses minor cannabinoids CB1 receptors preclinical research focusing on cannabidiphorol (CBDP). CBDP acts as a negative allosteric modulator at two distinct sites of the CB1 receptor. Understanding this modulation is crucial for future…
Radical Revelations: Nitrosative Stress and the Endocannabinoid System in Age-Related Disorders
This endocannabinoid system neurodegeneration research review highlights the critical role of ECS in modulating nitrosative stress pathways. Emerging evidence suggests ECS modulation may influence neuroinflammation and progression of age-related…
Cannabidiol in Developmental Epilepsy: Organoid-Guided Precision Medicine Across Critical Neurodevelopmental Windows.
CBD neurodevelopmental epilepsy research reveals promising precision medicine approaches targeting critical developmental windows. This review synthesizes evidence on CBD's neuroprotective and antiseizure effects in pediatric epilepsy. Understanding…